Baader Bank AG
Baader Bank AG acted as joint bookrunner in the successful EUR 20.7 Million capital increase of Medigene AG
DGAP-News: Baader Bank AG / Key word(s): Miscellaneous Baader Bank AG acted as joint bookrunner in the successful EUR 20.7 Million capital increase of Medigene AG Unterschleissheim, May 5, 2017: Baader Bank AG acted as joint bookrunner and settlement agent on the successful capital increase of Medigene AG (FSE: MDG1, Prime Standard, TecDAX), a biotech company based in Martinsried/Munich. As part of the capital raising exercise, Baader Bank successfully conducted a private placement of 1.9 Million shares with European and US institutional investors. For further Information or media inquiries: Katharina Ariane Beyersdorfer T +49 89 5150 1016
As an independent financial advisory firm, Baader Bank is an expert in the structuring and implementation of debt and equity capital raising, securities technology and has a team of experienced equity analysts and strategists. Baader Bank advises and supports dynamic companies across the German speaking region in realizing their financial objectives across a wide range of capital markets transactions.
05.05.2017 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English |
Company: | Baader Bank AG |
Weihenstephaner Str. 4 | |
85716 Unterschleissheim | |
Germany | |
Phone: | +49 89 5150 1013 |
Fax: | +49 89 5150 29 1880 |
E-mail: | communications@baaderbank.de |
Internet: | www.baaderbank.de |
ISIN: | DE0005088108 |
WKN: | 508810 |
Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich (m:access), Stuttgart, Tradegate Exchange; Open Market in Frankfurt |
End of News | DGAP News Service |